Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Anticancer, Inc. v. Pfizer, Inc. et al
Case Number:
3:11-cv-00107
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
October 14, 2016
Pfizer Settles Long-Running Cancer Research IP Suit
Pfizer Inc. has reached a settlement with AntiCancer Inc. to resolve claims the drug giant unlawfully terminated a patent licensing agreement for AntiCancer's research technology following Pfizer's 2009 merger with fellow pharmaceutical behemoth Wyeth.
-
January 20, 2011
Pfizer Sued Over Termination Of Wyeth Patent Pact
Pharmaceutical company Pfizer Inc. has been accused of unlawfully terminating a patent licensing agreement for imaging technology between AntiCancer Inc. and Wyeth following the merger of the two drug giants.